Preview

Experimental and Clinical Gastroenterology

Advanced search

Etiopathogenetic criteria for the diagnosis of hepatoblastoma in children

https://doi.org/10.31146/1682-8658-ecg-197-1-130-134

Abstract

A review article is devoted to diagnostical etiopathogenetic criteria of hepatoblastoma in pediatric patients. There is a distinguished cytogenetic analysis that detects only a limited amount of structural and numerical anomalies in hepatoblastomas; histopathological assessment of liver bioptats which facilitates treatment tactics. Distinctive laboratory findings in pediatric hepatoblastoma are microcytic anaemia, reactive thrombocytosis, and elevated alpha-fetoprotein. The immunohistochemical analysis allows the assessment of the nuclear expression of INI1 (SMARCB1) and the exclusion of malignant rhabdoid liver tumours. There is recommended hepatic doppler ultrasonography, as well as a three-dimensional assessment of primary tumour sizes and tumour volume to reveal the extent of hepatoblastoma according to the PRETEXT system. Radiography and computed tomography of the chest organs are advised to determine hepatoblastoma’s metastases.

About the Authors

I. V. Sadovnikova
Privolzhsky Research Medical University
Russian Federation


A. T. Egorskaia
Privolzhsky Research Medical University
Russian Federation


References

1. Feng J., Polychronidis G., Heger U., Frongia G., Mehrabi A., Hoffmann K. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun (Lond). 2019;39(1):62. doi:10.1186/s40880-019-0411-7

2. Ranganathan S., Lopez-Terrada D., Alaggio R. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatr Dev Pathol. 2020;23(2):79-95. doi:10.1177/1093526619875228

3. Ng K., Mogul D. B. Pediatric Liver Tumors. Clin Liver Dis. 2018;22(4):753-772. doi:10.1016/j.cld.2018.06.008

4. Ritz A., Kolorz J., Hubertus J., et al. Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma. Pediatr Blood Cancer. 2021;68(5): e28862. doi:10.1002/pbc.28862

5. Towbin A.J., Meyers R. L., Woodley H., et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol. 2018;48(4):536-554. doi:10.1007/s00247-018-4078-z

6. Adora Jovi Fernandes, RGW Pinto Hepatoblastoma: a case report.Russian News of Clinical Cytology. 2019;23(2):17-20. (in Russ.) doi:10.24411/1562-4943-2019-10203@@ Адора Дж.Ф., Вайсман Пинто Р. Г. Гепатобластома: описание клинического случая // Новости клинической цитологии России. 2019. № 2.

7. Bolshakova T.V., Kondratieva E. A. Application of fine needle aspiration and trepan biopsy in patients with hepatoblastoma. FORCIPE. 2019; Application:628. (in Russ.)@@ Большакова Т. В., Кондратьева Е. А. Применение тонкоигольной аспирационной и трепан - биопсии у пациентов с гепатобластомой // FORCIPE. 2019. Приложение. 628.


Review

For citations:


Sadovnikova I.V., Egorskaia A.T. Etiopathogenetic criteria for the diagnosis of hepatoblastoma in children. Experimental and Clinical Gastroenterology. 2022;(1):130-134. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-197-1-130-134

Views: 240


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)